Arcutis Biotherapeutics, Inc. (ARQT): Shareholders' Equity
$189.48M
As of 2025-12-31
$220.58M
As of 2026-06-30
-3.3%
3-year compound annual growth
-6.9%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $189.48M | +20.3% | 2026-02-25, Balance as of period end |
| 2024-12-31 | $157.54M | +77.7% | 2026-02-25, Balance as of period end |
| 2023-12-31 | $88.67M | -57.7% | 2026-02-25, Balance as of period end |
| 2022-12-31 | $209.58M | -29.6% | 2025-02-25, Balance as of period end |
| 2021-12-31 | $297.68M | +10.0% | 2024-02-27, Balance as of period end |
| 2020-12-31 | $270.62M | n/m | 2023-02-28, Balance as of period end |
| 2019-12-31 | -$65.03M | n/m | 2022-02-22, Balance as of period end |
| 2018-12-31 | -$23.99M | n/a | 2021-02-16, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | 2025-12-31 | $189.48M | +20.3% |
| Sinovac Biotech Ltd (SVA) | 2025-12-31 | $6.40B | -37.9% |
| MannKind Corp (MNKD) | 2025-12-31 | -$51.02M | n/m |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | $166.95M | -3.7% |
| Innoviva, Inc. (INVA) | 2025-12-31 | $1.17B | +69.7% |
| CorMedix Inc. (CRMD) | 2025-12-31 | $405.31M | +378.8% |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | $715.50M | -14.9% |
| Evolus, Inc. (EOLS) | 2025-12-31 | -$23.11M | n/m |
| Ironwood Pharmaceuticals Inc (IRWD) | 2025-12-31 | -$261.83M | n/m |
Compare ARQT, SVA, MNKD, ARDX side by side · Screen every company in Pharmaceutical Preparations ↗